[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100433882":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":20,"centralContacts":25,"locations":35,"responsibleParty":95,"collaborators":98,"id":104,"slug":19,"hasResults":105,"nctId":106,"briefTitle":107,"officialTitle":108,"acronym":19,"eligibilityCriteria":109,"healthyVolunteers":105,"sex":110,"minAge":111,"maxAge":112,"enrollmentInfo":113,"targetDuration":19,"studyType":116,"phases":117,"briefSummary":119,"conditions":120,"keywords":19,"overallStatus":38,"whyStopped":19,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":131},{"fullName":5,"class":6},"The Hospital for Sick Children","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Bright Ideas- CIN Training","The PSST will be delivered by a \"trainer\" in a minimum of three 30-minute to 1-hour sessions with a parent and patient (if developmentally appropriate).\n\nDuring the first session, the study team member will build rapport by understanding relevant personal background and medical information; introduce PSST and the Bright IDEAS paradigm; review the patients experience with nausea as reported in Phase 1 and at other times during treatment; promote problem-solving strategies and skills; and develop an anti-nausea action plan. During the second session, the trainer will discuss how well the prior action plan worked and reinforce successful outcomes or, if unsuccessful, return to the problem-solving steps to generate a new action plan. The third session will review progress on CINV control, assist in problem-solving as needed, and discuss how to continue to use the Bright IDEAS framework to resolve future issues with CINV or symptom management more broadly.",[12],"Behavioral: Bright Ideas - CIN Training",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","Bright Ideas - CIN Training","Bright IDEAS is a validated problem-solving skill training intervention.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Lee Dupuis, PhD","SickKids Research Institute","PRINCIPAL_INVESTIGATOR",[26,30],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},"CONTACT","416-813-7762","lee.dupuis@sickkids.ca",{"name":31,"role":27,"phone":32,"phoneExt":33,"email":34},"Tadi Hondonga","416-813-7654","309971","Tadi.hondonga@sickkids.ca",[36,53,67,81],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Children's Hospital Los Angeles","RECRUITING","Los Angeles","California","90027","United States",{"type":44,"coordinates":45},"Point",[46,47],-118.24368,34.05223,{"lat":47,"lon":46},[50],{"name":51,"role":27,"phone":19,"phoneExt":19,"email":52},"Lauren Guidry","lguidry@chla.usc.edu",{"facility":54,"status":38,"city":55,"state":56,"zip":57,"country":42,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Rutgers Cancer Institute","New Brunswick","New Jersey","08901",{"type":44,"coordinates":59},[60,61],-74.45182,40.48622,{"lat":61,"lon":60},[64],{"name":65,"role":27,"phone":19,"phoneExt":19,"email":66},"Katie Devine, PhD","katie.devine@rutgers.edu",{"facility":68,"status":38,"city":69,"state":70,"zip":71,"country":42,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Inova Children's Hospital","Falls Church","Virginia","22042",{"type":44,"coordinates":73},[74,75],-77.17109,38.88233,{"lat":75,"lon":74},[78],{"name":79,"role":27,"phone":19,"phoneExt":19,"email":80},"Robin Dulman","rdulman@psvcare.org",{"facility":82,"status":38,"city":83,"state":84,"zip":85,"country":86,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Hospital for Sick Children","Toronto","Ontario","M5G 1X8","Canada",{"type":44,"coordinates":88},[89,90],-79.39864,43.70643,{"lat":90,"lon":89},[93],{"name":22,"role":27,"phone":32,"phoneExt":94,"email":29},"309355",{"type":24,"investigatorFullName":96,"investigatorTitle":97,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Lee Dupuis","Senior Associate Scientist",[99,101,103],{"name":100,"class":6},"Rutgers Cancer Institute of New Jersey",{"name":102,"class":6},"Inova Fairfax Hospital",{"name":37,"class":6},"100433882",false,"NCT04929899","Bright Ideas - CIN Feasibility Study","Improving Chemotherapy-induced Nausea Control Through Bright Ideas®-CIN Training: a Feasibility Study in Children Receiving Oral Chemotherapy","Inclusion Criteria:\n\n* Age: ≥ 4 years (PeNAT validated in patients 4 to 18 yrs)\n* newly diagnosed or recurrent disease: first diagnosis of ALL (i.e. non-relapsed) in maintenance therapy\n* English, French or Spanish-speaking with an English, French or Spanish-speaking guardian (PeNAT available in these languages)\n* without physical or cognitive impairments that preclude use of the PeNAT\n* planned to receive PO 6-mercaptopurine\n* not planned to receive IV, IM, SC or IT chemotherapy or oral or IV corticosteroids during the 7-day study period","ALL","4 Years","18 Years",{"count":114,"type":115},75,"ESTIMATED","INTERVENTIONAL",[118],"NA","In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.",[121],"Acute Lymphoblastic Leukemia (ALL)","2025-01-28",{"date":124,"type":125},"2025-01-31","ACTUAL",{"date":127,"type":125},"2022-03-01",{"date":129,"type":115},"2025-06",{"name":5,"class":6},4]